Fiserv Inc. (FI)
Sector: | Information Technology |
Super Investor Stats: | |
Ownership count: | 10 |
Ownership rank: | 26 |
% of all portfolios: | 0.363% |
Hold Price * : | $179.65 |
History | Portfolio Manager | Activity ▼ | Share change | % change to portfolio | |
Q3  2024 | |||||
≡ | David Katz - Matrix Asset Advisors | Reduce 3.06% | 1,137 | 0.02 | |
≡ | Dodge & Cox | Reduce 5.60% | 1,300,800 | 0.21 | |
≡ | John Armitage - Egerton Capital | Reduce 5.78% | 158,255 | 0.29 | |
≡ | Samantha McLemore - Patient Capital Management | Reduce 30.68% | 58,820 | 0.52 | |
≡ | ValueAct Capital | Sell 100.00% | 1,103,759 | 4.63 | |
≡ | Mason Hawkins - Longleaf Partners | Sell 100.00% | 178,443 | 2.58 | |
Q2  2024 | |||||
≡ | Torray Funds | Reduce 0.07% | 110 | 0.00 | |
≡ | David Katz - Matrix Asset Advisors | Reduce 1.83% | 690 | 0.01 | |
≡ | Samantha McLemore - Patient Capital Management | Reduce 17.89% | 41,755 | 0.33 | |
≡ | John Armitage - Egerton Capital | Reduce 19.32% | 655,536 | 0.99 | |
≡ | ValueAct Capital | Reduce 69.81% | 2,551,882 | 10.70 | |
Q1  2024 | |||||
≡ | Torray Funds | Reduce 0.61% | 927 | 0.02 | |
≡ | John Armitage - Egerton Capital | Reduce 1.62% | 56,007 | 0.09 | |
≡ | Samantha McLemore - Patient Capital Management | Reduce 9.05% | 23,234 | 0.18 | |
≡ | ValueAct Capital | Reduce 12.73% | 533,200 | 1.88 | |
≡ | Mason Hawkins - Longleaf Partners | Reduce 45.67% | 149,986 | 2.11 | |
≡ | David Katz - Matrix Asset Advisors | Reduce 49.97% | 37,751 | 0.72 | |
Q4  2023 | |||||
≡ | John Armitage - Egerton Capital | Reduce 2.57% | 91,085 | 0.13 | |
≡ | Samantha McLemore - Patient Capital Management | Reduce 5.15% | 13,947 | 0.10 | |
≡ | Bill Nygren - Oakmark Select Fund | Reduce 5.92% | 82,588 | 0.19 | |
≡ | David Katz - Matrix Asset Advisors | Reduce 7.24% | 5,894 | 0.10 | |
≡ | ValueAct Capital | Reduce 44.51% | 3,360,000 | 8.94 | |
≡ | Lee Ainslie - Maverick Capital | Sell 100.00% | 5,087 | 0.01 | |
Q3  2023 | |||||
≡ | Dodge & Cox | Reduce 0.17% | 40,600 | 0.01 | |
≡ | David Katz - Matrix Asset Advisors | Reduce 0.92% | 760 | 0.01 | |
≡ | Torray Funds | Reduce 1.40% | 2,158 | 0.04 | |
≡ | Samantha McLemore - Patient Capital Management | Reduce 6.55% | 18,983 | 0.13 | |
≡ | Mason Hawkins - Longleaf Partners | Reduce 17.53% | 69,805 | 0.64 | |
≡ | ValueAct Capital | Reduce 35.19% | 4,098,935 | 10.40 | |
≡ | Lee Ainslie - Maverick Capital | Reduce 38.38% | 3,169 | 0.01 | |
Q2  2023 | |||||
≡ | Bill Nygren - Oakmark Select Fund | Reduce 0.02% | 312 | 0.00 | |
≡ | Torray Funds | Reduce 0.56% | 860 | 0.02 | |
≡ | David Katz - Matrix Asset Advisors | Reduce 1.93% | 1,616 | 0.03 | |
≡ | John Armitage - Egerton Capital | Reduce 3.38% | 118,355 | 0.15 | |
≡ | Mairs & Power Growth Fund | Reduce 4.07% | 42,000 | 0.11 | |
≡ | Mason Hawkins - Longleaf Partners | Reduce 14.21% | 65,983 | 0.63 | |
≡ | Bill Miller - Miller Value Partners | Sell 100.00% | 287,648 | 2.03 | |
≡ | Seth Klarman - Baupost Group | Sell 100.00% | 533,382 | 1.08 | |
Q1  2023 | |||||
≡ | Torray Funds | Reduce 0.14% | 215 | 0.00 | |
≡ | David Katz - Matrix Asset Advisors | Reduce 5.24% | 4,632 | 0.08 | |
≡ | Samantha McLemore - Patient Capital Management | Reduce 18.93% | 12,475 | 0.63 | |
≡ | ValueAct Capital | Reduce 20.48% | 3,000,000 | 5.52 | |
≡ | Bill Miller - Miller Value Partners | Reduce 24.80% | 94,842 | 0.67 | |
≡ | Mason Hawkins - Longleaf Partners | Reduce 28.92% | 188,895 | 1.69 | |
≡ | Seth Klarman - Baupost Group | Reduce 73.36% | 1,469,009 | 2.97 | |
Q4  2022 | |||||
≡ | David Katz - Matrix Asset Advisors | Reduce 2.64% | 2,402 | 0.04 | |
≡ | Samantha McLemore - Patient Capital Management | Reduce 11.78% | 8,800 | 0.44 | |
≡ | Bill Miller - Miller Value Partners | Reduce 20.94% | 101,302 | 0.66 | |
≡ | Bill Nygren - Oakmark Select Fund | Reduce 30.06% | 600,000 | 1.49 | |
≡ | Seth Klarman - Baupost Group | Reduce 43.31% | 1,530,000 | 2.63 | |
Q3  2022 | |||||
≡ | Samantha McLemore - Patient Capital Management | Reduce 1.97% | 1,500 | 0.07 | |
≡ | Mairs & Power Growth Fund | Reduce 4.54% | 49,000 | 0.11 | |
≡ | Bill Nygren - Oakmark Select Fund | Reduce 13.22% | 304,000 | 0.71 | |
≡ | Bill Miller - Miller Value Partners | Reduce 17.84% | 105,021 | 0.60 | |
≡ | Leon Cooperman | Reduce 48.26% | 415,000 | 2.72 | |
≡ | Torray Funds | Reduce 71.98% | 143,557 | 2.67 | |
Q2  2022 | |||||
≡ | Torray Funds | Reduce 5.86% | 12,407 | 0.21 | |
≡ | Bill Miller - Miller Value Partners | Reduce 6.43% | 40,468 | 0.20 | |
≡ | Seth Klarman - Baupost Group | Reduce 11.43% | 456,000 | 0.62 | |
≡ | Leon Cooperman | Reduce 16.55% | 170,600 | 1.04 | |
≡ | David Katz - Matrix Asset Advisors | Reduce 28.32% | 34,815 | 0.47 | |
Q1  2022 | |||||
≡ | Mairs & Power Growth Fund | Reduce 6.90% | 80,000 | 0.15 | |
≡ | Bill Nygren - Oakmark Select Fund | Reduce 9.80% | 250,000 | 0.52 | |
Q4  2021 | |||||
≡ | Torray Funds | Reduce 0.36% | 734 | 0.01 | |
≡ | Harry Burn - Sound Shore | Sell 100.00% | 340,300 | 3.02 | |
Q4  2020 | |||||
≡ | Torray Funds | Reduce 4.50% | 2,660 | 0.05 | |
≡ | John Armitage - Egerton Capital | Sell 100.00% | 2,190,709 | 1.39 | |
Q3  2020 | |||||
≡ | John Armitage - Egerton Capital | Reduce 42.38% | 1,610,959 | 1.02 | |
≡ | Lee Ainslie - Maverick Capital | Sell 100.00% | 9,382 | 0.02 | |
Q2  2020 | |||||
≡ | John Armitage - Egerton Capital | Reduce 41.48% | 2,694,178 | 1.96 | |
Q1  2020 | |||||
≡ | Mairs & Power Growth Fund | Reduce 2.99% | 30,000 | 0.08 | |
≡ | John Armitage - Egerton Capital | Reduce 15.79% | 1,218,237 | 1.20 | |
Q4  2019 | |||||
≡ | Mairs & Power Growth Fund | Reduce 19.92% | 250,000 | 0.63 | |
≡ | Torray Funds | Reduce 74.96% | 169,022 | 3.35 | |
≡ | Lee Ainslie - Maverick Capital | Sell 100.00% | 608,351 | 0.93 | |
Q3  2019 | |||||
≡ | Torray Funds | Reduce 5.80% | 13,873 | 0.16 | |
≡ | Mairs & Power Growth Fund | Reduce 8.73% | 120,000 | 0.29 | |
≡ | Lee Ainslie - Maverick Capital | Reduce 52.57% | 674,299 | 1.03 | |
Q2  2019 | |||||
≡ | Torray Funds | Reduce 2.74% | 6,752 | 0.06 | |
≡ | John Armitage - Egerton Capital | Reduce 38.37% | 2,469,277 | 1.65 | |
≡ | Lee Ainslie - Maverick Capital | Reduce 60.10% | 1,931,996 | 2.55 | |
Q1  2019 | |||||
≡ | Torray Funds | Reduce 12.05% | 33,729 | 0.31 | |
Q4  2018 | |||||
≡ | Mairs & Power Growth Fund | Reduce 1.79% | 25,000 | 0.05 | |
≡ | Torray Funds | Reduce 3.90% | 11,364 | 0.10 | |
Q1  2018 | |||||
≡ | Mairs & Power Growth Fund | Reduce 2.10% | 30,000 | 0.05 | |
Q4  2017 | |||||
≡ | Mairs & Power Growth Fund | Reduce 0.69% | 10,000 | 0.01 | |
Q3  2017 | |||||
≡ | Mairs & Power Growth Fund | Reduce 7.69% | 120,000 | 0.18 | |
Q2  2016 | |||||
≡ | Mairs & Power Growth Fund | Reduce 2.50% | 40,000 | 0.05 | |
Q1  2016 | |||||
≡ | Mairs & Power Growth Fund | Reduce 3.61% | 60,000 | 0.08 | |
Q4  2015 | |||||
≡ | Mairs & Power Growth Fund | Reduce 2.35% | 40,000 | 0.05 | |
Q3  2015 | |||||
≡ | Mairs & Power Growth Fund | Reduce 15.00% | 300,000 | 0.36 | |
Q2  2015 | |||||
≡ | Mairs & Power Growth Fund | Reduce 7.41% | 160,000 | 0.16 | |
Q1  2015 | |||||
≡ | Mairs & Power Growth Fund | Reduce 9.24% | 220,000 | 0.21 | |
Q4  2014 | |||||
≡ | Mairs & Power Growth Fund | Reduce 7.97% | 206,240 | 0.17 | |
Q2  2014 | |||||
≡ | Mairs & Power Growth Fund | Reduce 0.77% | 20,000 | 0.01 | |
Q3  2013 | |||||
≡ | Glenn Greenberg - Brave Warrior Advisors | Sell 100.00% | 4,488,724 | 4.54 | |
Q2  2013 | |||||
≡ | Glenn Greenberg - Brave Warrior Advisors | Reduce 22.01% | 1,266,884 | 1.28 | |
Q4  2012 | |||||
≡ | Glenn Greenberg - Brave Warrior Advisors | Reduce 17.53% | 1,199,816 | 1.42 | |
Q3  2012 | |||||
≡ | Glenn Greenberg - Brave Warrior Advisors | Reduce 24.16% | 2,180,616 | 2.50 | |
Q1  2012 | |||||
≡ | Glenn Greenberg - Brave Warrior Advisors | Reduce 13.69% | 1,300,328 | 1.66 |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.